Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Daniel Eun MD

Daniel D. Eun MD

Professor of Urology, Lewis Katz School of Medicine at Temple University; Chief of Robotic Surgical Services, Director of Minimally Invasive Robotic Urologic Oncology and Reconstructive Surgery, Temple University Hospital, Philadelphia, PA

Current Titles and Positions at Lewis Katz School of Medicine at Temple University & Temple University Hospital

  • Professor of Urology
  • Chief of Robotic Surgical Services
  • Director of Robotic Urologic Oncology & Reconstructive Surgery
  • Director of Robotic Urologic Surgery Clinical Fellowship Program

Dr. Eun earned his BS in Biology from Pennsylvania State University, MD from Temple University School of Medicine, and general surgery internship at the University of Pennsylvania. Dr. Eun then completed his urology residency and 18-month minimally invasive urologic robotic oncology fellowship at Henry Ford Hospital’s Vattikuti Urology Institute in Detroit.

In 2008, he took his first appointment at the University of Pennsylvania as an Assistant Professor of Urology/Surgery and Director of Robotic Urologic Oncology & Reconstructive Surgery at Pennsylvania Hospital. He quickly built the program into one of the busiest robotic kidney surgery programs in the world at the time and a regional reputation for handling complex oncologic and reconstructive cases. In 2012, Dr. Eun was recruited to bring his robotic surgery program to his alma mater, Temple University, in Philadelphia.

Dr. Eun currently runs a regional and national high-volume referral practice for robotic treatment of genitourinary oncology as well as complex reconstructive surgery of the kidney, ureter, prostate and bladder. He currently has one of the busiest complex robotic reoperative and reconstructive practices in the world. He has performed over 4000 robotic procedures and more than 50 different types of robotic procedures. Dr. Eun is regarded as a thought leader in advanced robotic surgery techniques, robotic procedure development and advanced level robotic surgical training.

Since 2008, Dr. Eun has offered a fellowship and currently offers a one-year fellowship in robotic urologic oncology and reconstructive surgery at Temple University Hospital. He has extensively published peer-reviewed journal articles, book chapters and video teaching guides. Dr. Eun has taught numerous robotics masters-level classes, resident/fellow courses in robotics and lectured in over a dozen countries and for numerous international societies and training programs. He has performed over 50 live robotic surgery demonstrations at various international university medical centers and at large conference venues such as the American Urologic Association and North American Robotic Urologic Symposium. In 2015, Dr. Eun was appointed as an honorary Professor of Urology at Nanchang University in the People’s Republic of China for his numerous teaching contributions.

As director of Temple’s Advanced Robotic Urologic Surgery Fellowship Training Program and Chief of Robotic Surgical Services, Dr. Eun is an active member of the teaching faculty of Temple University School of Medicine, working closely with medical students, residents and fellows.


Financial Disclosures

  • Intuitive Surgical: Consultant, teaching activities
  • Medtronic: Consultant
  • Johnson and Johnson: Consultant 
  • Histiosonics: Advisory Board
  • Hitachi Medical: Grant support 
  • Melzi Corp.: Sharholder, Advisory Board